Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

The Positive Prognostic Value of Stress Echocardiography - AMPHIPOLIS STUDY

The Prognostic Value of Positive Stress Echocardiography and Its Relationship with Invasive Coronary Angiography: the AMPHIPOLIS Study

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a prospective, multicenter, observational study of patients with recent stress echocardiography positive for myocardial ischemia. Up to now 25 echocardiography labs form Greece and Cyprus have declared their intention to participate. The investigators will enroll 390 patients with a positive stress echo, who will undergo invasive coronary angiogram and then will be followed up for at least 6 months. The objectives are the following: 1. To assess the prognostic value of positive stress echo by monitoring for cardiovascular death and major adverse cardiovascular events (MACE) during the follow-up. 2. To investigate the relationship of stress echo findings with invasive coronary angiography anatomical findings. 3. The association of cardiovascular risk profile of participants with stress echo and coronary angiography findings.

Who May Be Eligible (Plain English)

Who May Qualify: Patients with recent stress echocardiography positive for any extent of myocardial ischemia Who Should NOT Join This Trial: 1. HFrEF requiring viability study. 2. Any symptomatic valvular disease causing symptoms. 3. Established or suspected cardiomyopathy. 4. Concomitant chronic diseases reducing life expectancy (active cancer, severe liver impairment, auto-immune diseases etc). 5. Recent acute coronary syndrome the last week. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Patients with recent stress echocardiography positive for any extent of myocardial ischemia Exclusion Criteria: 1. HFrEF requiring viability study. 2. Any symptomatic valvular disease causing symptoms. 3. Established or suspected cardiomyopathy. 4. Concomitant chronic diseases reducing life expectancy (active cancer, severe liver impairment, auto-immune diseases etc). 5. Recent acute coronary syndrome the last week.

Locations (1)

Hellenic Society of Cardiology
Athens, Attica, Greece